TYRPHOSTIN AG 1296 Chemical Properties

Boiling point:

420.2±40.0 °C(Predicted)

Density 

1.192±0.06 g/cm3(Predicted)

storage temp. 

Keep in dark place,Sealed in dry,Store in freezer, under -20°C

solubility 

Soluble in DMSO.

form 

White solid

pka

0.48±0.30(Predicted)

color 

Yellow

Sensitive 

Light Sensitive

Stability:

Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.

Safety Information

WGK Germany 

3

MSDS

• Language:English Provider:SigmaAldrich

TYRPHOSTIN AG 1296 Usage And Synthesis

Description

Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors specific for platelet-derived growth factor (PDGF) receptor kinase could help in the treatment of atherosclerosis, restenosis, pulmonary fibrosis, and gliomas. AG-1296 is a potent and selective inhibitor of PDGF receptor kinase with an IC₅₀ value of about 0.4 μM both in vitro and in cells (Swiss 3T3 cells). It inhibits ligand-stimulated DNA synthesis in platelet-derived growth factor receptor and stem cell factor/kit receptor transfected cells with an IC₅₀ values of 1.5 and 1.8 μM, respectively. Treatment of sis oncogene transfected NIH3T3 cells with AG-1296 reverses the transformed phenotype.

Uses

Tyrphostin AG 1296, is the platelet-derived growth factor receptor (PDGFR) inhibitor, which can causes growth inhibition in glioblastoma cells.

Definition

ChEBI: 6,7-dimethoxy-2-phenylquinoxaline is a quinoxaline derivative.

Synthesis

GENERAL METHODS: Triphenyltin (35.5 mg, 0.1 mmol, 10 mol%) and 4,5-dimethoxy-1,2-phenylenediamine (1.2 mmol) were sequentially added to a solution of 2-hydroxyacetophenone (1 mmol) in toluene (6 mL) under air atmosphere. The reaction mixture was stirred at room temperature and the progress of the reaction was monitored by thin layer chromatography (TLC). Upon completion of the reaction, the solvent was removed by concentration under reduced pressure and the resulting residue was purified by silica gel column chromatography with dichloromethane (CH2Cl2) as eluent. The structure of the final product, 6,7-dimethoxy-2-phenylquinoxaline, was analyzed by melting point determination, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) and confirmed by comparison with literature data.

in vivo

target

PDGFR

IC 50

PDGFRα; PDGFRβ

References

[1] MARINA KOVALENKO. Phosphorylation Site-Specific Inhibition of Platelet-Derived Growth Factor β-Receptor Autophosphorylation by the Receptor Blocking Tyrphostin AG1296[J]. Biochemistry Biochemistry, 1997, 36 21: 6260-6269. DOI:10.1021/bi962553l
[2] G W KRYSTAL  J L  P Carlson. Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.[J]. Cancer research, 1997, 57 11: 2203-2208.
[3] F. STRUTZ. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).[J]. Kidney international, 2001, 69 1: 579-592. DOI:10.1046/j.1523-1755.2001.059002579.x

TYRPHOSTIN AG 1296(146535-11-7)Related Product Information

• 4-HYDROXYBENZYLIDENEMALONONITRILE
• TYRPHOSTIN A25
• AG 490
• AAL-993
• Cantharidin
• TYRPHOSTIN AG 879
• TYRPHOSTIN B56
• AG 957
• TYRPHOSTIN AG 1024
• ZM 323881 hydrochloride
• AZD-4547
• FGFR inhibitor
• Bosutinib
• Saracatinib
• 4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-ylamino)phenol
• Tyrphostin AG1433
• AG 18
• TYRPHOSTIN A1